Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Podcasts
Resources
Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Podcasts
Resources
Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Harvard Medical School
Research
New heart failure findings open door to personalized therapies
Individual genetic factors could lead to differing pathways to heart failure, a discovery that paves the way for personalized therapies.
Gabrielle Masson
Aug 4, 2022 2:00pm
Easing blood clotting through a new pathway
Jan 11, 2022 7:10am
Fighting drug-resistant cancer by blocking an escape route
Jan 5, 2022 8:35am
Luxturna inventor launches new gene therapy biotech with $19M
Sep 22, 2021 10:05am
The immune connection between mutated genes and cancer
Sep 16, 2021 2:00pm
Study of dogs and cats sheds light on key immune pathways
Aug 6, 2021 2:00pm